Publicaciones en las que colabora con José Luis Vila Jato (18)

1998

  1. Effect of norfloxacin complexation with β-cyclodextrin on the in vitro dissolution behaviour and its interaction with Mg2+ and Al3+

    Journal of Thermal Analysis and Calorimetry, Vol. 51, Núm. 3, pp. 1009-1021

1990

  1. Prediction of tablet properties by compression force-time profile parameters

    Drug Development and Industrial Pharmacy, Vol. 16, Núm. 2, pp. 231-241

  2. The effect of maximum compression force and drug content on compression force-time cprofile parameters

    Drug Development and Industrial Pharmacy, Vol. 16, Núm. 2, pp. 243-254

1989

  1. Technological factors and release in matricial systems. I . Plastic matrixes

    Ciencia e Industria Farmaceutica, Vol. 8, Núm. 7-9, pp. 184-190

  2. Use of the crushing strength parameter for quality control of phenobarbital-microcrystalline cellulose tablets

    Farmaco, Vol. 44, Núm. 7-8, pp. 731-737

1988

  1. Effect of compression force on biopharmaceutical characteristics of Eudragit RS-based cephalexin tablets

    International Journal of Pharmaceutics, Vol. 47, Núm. 1-3, pp. 37-42

1987

  1. Dissolution rate and bioavailability of spironolactone tablets: Effect of various technological factors

    Drug Development and Industrial Pharmacy, Vol. 13, Núm. 12, pp. 2301-2314

  2. Effect of different factors on stability of ceftriaxone in solution

    Farmaco, Edizione Pratica, Vol. 42, Núm. 5, pp. 131-137

  3. El diseño experimental en biofarmacia

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 3, pp. 37-43

  4. The use of compression force to control the quality of directly compressed phenobarbital formulations

    Drug Development and Industrial Pharmacy, Vol. 13, Núm. 14, pp. 2519-2527

1986

  1. Aging of nitrofurantoin tablets containing Carbopol 934 as a binder

    International Journal of Pharmaceutics, Vol. 30, Núm. 2-3, pp. 229-236

  2. Controlled release of cephalexin from double-layer tablets containing small proportions of acrylic resins

    International Journal of Pharmaceutics, Vol. 32, Núm. 2-3, pp. 99-102

  3. EFECTO DEL pH Y FLUJO URINARIO SOBRE LA EVALUACION DE LA BIODISPONIBILIDAD ORAL DE LA SULFADIAZINA

    Ciencia e Industria Farmaceutica, Vol. 5, Núm. 10, pp. 309-315

  4. INESTABILIDAD QUIMICA, GALENICA Y BIOFARMACEUTICA DE COMPRIMIDOS DE DIGOXINA-EMCOMMPRESS

    Ciencia e Industria Farmaceutica, Vol. 5, Núm. 1, pp. 12-20

1985

  1. Influence of storage conditions on the characteristics of digoxin-Emcompress tablets

    Sciences Techniques et Pratiques Pharmaceutiques, Vol. 1, Núm. 3, pp. 194-200

1984

  1. APPLICATION DU MANOVA DES MOMENTS STATISTIQUES DANS UNE ETUDE DE LA BIODISPONIBILITE DE TROIS FORMULATIONS DE PARACETAMOL

    Pharmaceutica Acta Helvetiae, Vol. 59, Núm. 4, pp. 109-111

1982

  1. BIODISPONIBILIDAD ORAL DE CEFADROXIL: INFLUENCIA DE LOS ALIMENTOS

    Archivos de Farmacologia y Toxicologia, Vol. 8, Núm. 3, pp. 171-178

1981

  1. DETERMINACION DE PARACETAMOL Y OXIFENBUTAZONA EN PLASMA POR CROMATOGRAFIA EN FASE LIQUIDA DE ALTA PRESION

    Bollettino Chimico Farmaceutico, Vol. 120, Núm. 3, pp. 165-171